As per the research report, the size of the European Dermatology Diagnostic Devices market is valued at USD 8.47 billion in 2023. It is expected to grow at a CAGR of 7.3% to reach USD 12.05 billion by 2028 during the forecast period 2023 to 2028.
The increase in the incidence of skin problems throughout the area is likely to fuel the growth of the Europe dermatology diagnostic devices market in the forecast years. Furthermore, the dermatology diagnostic devices market in Europe is expected to develop due to the preferred innovations of beauty improvement professionals and an increase in public knowledge about the aesthetic appeal and technological advancements in dermatology devices.
The need for non-invasive cosmetic repair procedures and a trend away from traditional items and toward technologically advanced equipment are expected to support the dermatology diagnostic devices market's expansion. Furthermore, the development of technologically advanced medicines in the upcoming years will create further chances for the dermatology diagnostic devices market to flourish.
Various contaminants, such as polycyclic aromatic hydrocarbons, oxides, and UV radiation, produce oxidative stress, damaging the skin. In addition, due to rapidly increasing levels of air pollution, a rise in the incidence of skin diseases, particularly hair loss, acne, eczema, and psoriasis, has led to an increase in demand for dermatology diagnostic devices across the continent.
Dermatology procedures have also acquired popularity in the cosmetics sector for various diagnostic services for people with chronic skin disorders such as pigmentation, allergic reactions, benign skin growth, and fungal or bacterial infections.
Diagnostic devices are costly and have a high price, restricting the dermatology diagnostic device market's growth in Europe. In addition, advanced technology requires professionals, but because practitioners are unfamiliar with more effective skin problems, the need for diagnostic equipment and practitioners who operate under dermatologists may be harmed.
The COVID-19 outbreak wreaked havoc on the dermatology product sector. The closure of non-essential businesses has impacted the dermatological industry, and consumers are now choosing cosmetic home treatments through the internet. In addition, the hospital must postpone non-urgent emergency operations and surgical procedures until the COVID-19 crisis has passed, and patients' treatment must be uninterrupted. As a result, the dermatology diagnostic equipment market has been severely harmed, with several reductions.
This research report on the Europe Dermatology Diagnostic Devices Market has been segmented and sub-segmented into the following categories.
By Type:
By Application:
By Dermatoscopes:
By Country:
Geographically, the Europe Dermatology Diagnostic Devices Market is expected to grow significantly and is transforming, with a shift toward more minor invasive diagnostic treatments. Dermatology diagnostic equipment makes diagnosis both simple and painless. Additionally, these gadgets aid in diagnosing several skin illnesses, such as Melanoma. Aside from that, dermatoscopy aids in better diagnosis, even beyond what the naked eye can see.
The U.K Dermatology Diagnostic Devices Market would have a larger market share due to the rising frequency of skin illnesses in Europe has aided the market's expansion. Furthermore, rising public awareness of cosmetic operations has boosted the market's potential. Furthermore, as the level of living rises, so will the need for high-quality healthcare, resulting in more opportunities.
The Germany Dermatology Diagnostic Devices Market is expected to dominate the European Dermatology Diagnostic Devices market due to the increased demand for dermatological equipment, primarily due to the rising prevalence of skin cancer and other skin illnesses. Market companies are diversifying their dermatology device portfolios by strengthening their existing product portfolios and continuing to innovate in the devices that are already on the market. Likewise, these companies are pursuing expansion plans to broaden their product offerings, strengthen their geographic reach, and extend their consumer base.
KEY MARKET PLAYERS
Key players dominating the Europe Dermatology Diagnostic Devices Market profiled in this report are 3Gen Inc, Bruker Corporation, Carl Zeiss (Germany), Genesis Biosystems, Inc., Alma Lasers, Ltd., Cutera, Inc, Cynosure, Inc, Lumenis Ltd, Valeant Pharmaceuticals, HEINE Optotechnik GmbH & Co. KG (Germany), Michelson Diagnostics (U.K.), and PhotoMedex, Inc.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region